Efficacy and Safety Study of rhGM-CSF Gel to Treat Deep 2nd Thickness Burn

Exclusion Criteria

• •age is less than 3 years old
• •the subject who participated in any other clinical trial within 3 months
• •the subject who was administrated with any other topical drug on wound surface before enrolled in the clinical study
• •the female subject who is in lactation or pregnancy
• •the subject who are allergic to rhGM-CSF, or has the allergic history to many drug products or has the allergic disease recently
• •the subject who has serious heart disease, unstable angina pectoris break out, cardiac functional insufficiency, myocardial infarction or serious general infection.
• •the subject who has serious renal inadequacy, creatinine(Cr) is more than 2.5 times of the upper limit
• •aspartate aminotransferase or alanine transpeptidase is more than 2.5 times of the upper limit
• •the subject who use immunosuppressant